United States - English - NLM (National Library of Medicine)

e-z-em canada inc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 1 mg in 1 ml - for use in computed tomography to opacify the gi tract. this product should not be used in patients with known or suspected gastrointestinal perforation or hypersensitivity to barium sulfate or any component of this barium sulfate formulation.

United States - English - NLM (National Library of Medicine)

e-z-em canada inc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 9.5 g in 23 g - for use in computed tomography of the gi tract. this product should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate products.

United States - English - NLM (National Library of Medicine)

e-z-em, inc. - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 700 mg - e-z-disk is indicated for use in radiography of the esophagus, for detection of esophageal strictures. barium sulfate products for radiographic procedures should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate formulations.

United States - English - NLM (National Library of Medicine)

e-z-em canada inc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 1.05 g in 1 ml - for radiography of the gastrointestinal tract. this product should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate products. this product should not be used in patients with known intestinal perforation or hypersensitivity to barium sulfate products.

United States - English - NLM (National Library of Medicine)

e-z-em canada inc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate .6 g in 1 g - for use in single contrast radiography of the esophagus, pharynx, hypopharynx and for cardiac series. this product should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate products.

United States - English - NLM (National Library of Medicine)

genus medical technologies, llc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 98 g in 100 g - this product should not be used in patients with known or suspected gastric or intestinal perforation, patients with conditions that may increase the risk of perforation; hypersensitivity to barium sulfate products; suspected tracheoesophageal fistula; obstructing lesions of the small intestine; pyloric stenosis; inflammation or neoplastic lesions of the rectum; or in patients who have had a recent rectal biopsy. barium sulfate suspensions should not be used for infants with swallowing disorders or for newborns with complete duodenal or jejunal obstruction or when distal small bowel or colon obstruction is suspected. barium sulfate suspension is not recommended for very small preterm infants and young babies requiring small volumes of contrast media or for infants and young children when there is a possibility of leakage from the gastrointestinal tract, such as nectrotizing enterocolitis, unexplained pneumoperitoneum, gasless abdomen, other bowel perforation, esophageal perforation or post operative anastomos

United States - English - NLM (National Library of Medicine)

genus medical technologies, llc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 96 g in 100 g - for use as a contrast agent in radiographic studies. this product should not be used in patients with known or suspected gastric or intestinal perforation, patients with conditions that may increase the risk of perforation; hypersensitivity to barium sulfate products; suspected tracheoesophageal fistula; obstructing lesions of the small intestine; pyloric stenosis; inflammation or neoplastic lesions of the rectum; or in patients who have had a recent rectal biopsy. barium sulfate suspensions should not be used for infants with swallowing disorders or for newborns with complete duodenal or jejunal obstruction or when distal small bowel or colon obstruction is suspected. barium sulfate suspension is not recommended for very small preterm infants and young babies requiring small volumes of contrast media or for infants and young children when there is a possibility of leakage from the gastrointestinal tract, such as nectrotizing enterocolitis, unexplained pneumoperitoneum, gasless abdomen, other bowel perforatio

Israel - English - Ministry of Health

promedico ltd - barium sulfate - powder for suspension - barium sulfate 96.476 %w/w - barium sulfate without suspending agents - barium sulfate without suspending agents - for rectal administration (enema) as a radio-opaque agent for x-ray visualisation of the lower gastro-intestinal tract. it is designed for both single contrast barium enema and air-double contrast enema usage.

Israel - English - Ministry of Health

promedico ltd - barium sulfate - suspension - barium sulfate 4.9224 %w/v - barium sulfate containing x-ray contrast media - for use in x-ray departments.opacification of the gastro intestinal tract prior to computerized axial tomography.

Canada - English - Health Canada

tyco healthcare - barium sulfate - suspension - 51% - barium sulfate 51% - roentgenography